Research and Development Leveraging Proprietary Optical Technology
First written in FY2016-Q3. 25 of 30 entries say "Restated". Latest entry: FY2026-H1.
96 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The company worked to secure revenue and profit by continuously promoting research and product development leveraging its proprietary optical technologies, enabling it to respond flexibly to changes in the market environment.」
The company states that there were no material changes to its policy of continuing research and product development using its proprietary optical technologies, and that R&D expenses were ¥9,189 million. - 2026-05-14RestatedRevision of earnings forecasts
「By continuing to actively promote research and product development that harnesses the Company's proprietary optical technologies,」
The continued pursuit of research and product development using the Company's proprietary optical technologies has been reaffirmed. - FY2025-H1RestatedAnnual report
「The total R&D expenses for the current interim consolidated accounting period were ¥8,701 million. There were no material changes in R&D activities during the current interim consolidated accounting period.」
The company states that it continued research and product development using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥8,701 million. - FY2024-Q2RestatedAnnual report
「The total R&D expenses for the second quarter of the current consolidated cumulative period were ¥6,141 million. There were no material changes in R&D activities during the second quarter of the current consolidated cumulative period.」
The company reconfirmed that it continued research and product development using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥6,141 million. - FY2024-Q1RestatedAnnual report
「The total R&D expenses for the first quarter of the current consolidated cumulative period were ¥3,101 million. There were no material changes in R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued research and product development using its proprietary optical technologies and recorded ¥3,101 million in R&D expenses. It states that there were no material changes in its R&D activities. - FY2023-Q3RestatedAnnual report
「The total R&D expenses for the third quarter of the current consolidated cumulative period were ¥8,907 million. There were no material changes in R&D activities during the third quarter of the current consolidated cumulative period.」
The company reconfirmed that it continued research and product development using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥8,907 million. - FY2023-Q2RestatedAnnual report
「The total R&D expenses for the second quarter of the current consolidated cumulative period were ¥5,769 million. There were no material changes in R&D activities during the second quarter of the current consolidated cumulative period.」
The company states that it continued research and product development using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥5,769 million. - FY2023-Q1RestatedAnnual report
「The total R&D expenses for the first quarter of the current consolidated cumulative period were ¥2,800 million. There were no material changes in R&D activities during the first quarter of the current consolidated cumulative period.」
The company states that it continued R&D using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥2,800 million. - FY2022AdvancedAnnual report
「Developed the world's first terahertz image intensifier capable of real-time imaging」
The company reports ¥11,269 million in R&D expenses and cites specific development achievements, including a terahertz image intensifier, an APD array for industrial LiDAR, a laser-based technology for producing anticancer drug nanoparticles, and a tunable-frequency terahertz quantum cascade laser module. - FY2022-Q3RestatedAnnual report
「The company continued proactive capital investment for the post-pandemic period and promoted R&D leveraging its proprietary optical technologies. The total R&D expenses for the third quarter of the current consolidated cumulative period were ¥7,969 million. There were no material changes in R&D activities during the third quarter of the current consolidated cumulative period.」
The company states that it continued capital investment in anticipation of the post-pandemic period and R&D using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses were ¥7,969 million. - FY2022-Q2RestatedAnnual report
「The total R&D expenses for the second quarter of the current consolidated cumulative period were ¥5,216 million. There were no material changes in R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued R&D leveraging its proprietary optical technologies and recorded ¥5,216 million in R&D expenses. It reconfirmed that there were no material changes in its R&D activities. - FY2022-Q1RestatedAnnual report
「The company has worked to secure revenue and profit by continuing R&D and product development that leverage its proprietary optical technologies, while implementing measures to prevent the spread of COVID-19 and remaining mindful of its contribution to a sustainable society. The total R&D expenses for the first quarter of the current consolidated cumulative period were ¥2,628 million. There were no material changes in R&D activities during the first quarter of the current consolidated cumulative period.」
The company states that it will continue R&D and product development using its proprietary optical technologies, with no material changes in its R&D activities. R&D expenses for the first quarter were ¥2,628 million. - FY2021AdvancedAnnual report
「By completely redesigning the photocathode and electrode structure, we newly developed a photomultiplier tube that approximately doubles light sensitivity and measurement accuracy compared with photomultiplier tubes for Super-Kamiokande, while minimizing detector-related noise.」
The company reports ¥11,367 million in R&D expenses and cites several specific development achievements, including photomultiplier tubes for Hyper-Kamiokande, scheduled to begin operations in 2027, a profile sensor with built-in processing capabilities, the ORCA-Quest CMOS camera for scientific measurement, a 250-joule-class industrial pulsed laser, and metalenses that improve photosensitivity by approximately 10%. - FY2021-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥8,330 million. There were no material changes in research and development activities during the nine-month period.」
Research and development leveraging proprietary optical technologies has continued, and the company stated that there were no material changes in research and development activities. Research and development expenses were ¥8,330 million. - FY2021-Q2RestatedAnnual report
「Under these circumstances, while continuing to operate after implementing measures to prevent COVID-19 infections, we have worked to secure revenue and profits by pursuing product development addressing market requirements and research and development leveraging our proprietary optical technologies. Total research and development expenses for the six months ended 30 September of the current fiscal year were ¥5,560 million. There were no material changes in research and development activities during the six-month period.」
Product development addressing market requirements and research and development leveraging proprietary optical technologies have continued, and the company stated that there were no material changes in research and development activities. Research and development expenses were ¥5,560 million. - FY2021-Q1RestatedAnnual report
「Total research and development expenses for the three months ended 30 June of the current fiscal year were ¥2,845 million. There were no material changes in research and development activities during the three-month period.」
Research and development leveraging proprietary optical technologies and product development addressing market requirements have continued, and the company stated that there were no material changes in research and development activities. Research and development expenses were ¥2,845 million. - FY2020AdvancedAnnual report
「By reviewing the materials and electrode structure from the ground up and optimizing the optical design, we increased measurement sensitivity to more than 10 times the previous level.」
The company reported research and development expenses of ¥12,147 million and specific development achievements, including measurement instruments for COVID-19 test reagents with more than 10 times the previous sensitivity, a portable FTIR spectrometer, a CMOS camera for scientific measurement, and a spatial light modulator with more than 10 times the previous light resistance. - FY2020-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥9,163 million. There were no material changes in research and development activities during the nine-month period.」
The company stated that there were no material changes in research and development activities, and that research and development expenses for the current nine-month period were ¥9,163 million. - FY2020-Q2RestatedAnnual report
「Under these circumstances, while taking into account the impact of COVID-19 on the global economy, we have worked to minimize business risks, including by maintaining a stable supply of our products. At the same time, while strengthening our sales structure and advancing capital investment in preparation for future revenue growth, we have worked to secure revenue and profits by continuously promoting product development addressing customer needs and research and development leveraging our proprietary optical technologies.」
Product development addressing customer needs and research and development leveraging proprietary optical technologies have continued. Research and development expenses were ¥6,275 million, and there were no material changes in research and development activities. - FY2020-Q1RestatedAnnual report
「Under these circumstances, we have worked to secure revenue and profits by continuing research and development leveraging our proprietary optical technologies and proactive capital investment for the future. Total research and development expenses for the three months ended 30 June of the current fiscal year were ¥2,862 million. There were no material changes in research and development activities during the three-month period.」
The policy of continuing research and development leveraging proprietary optical technologies and capital investment was reiterated, and research and development expenses of ¥2,862 million and the absence of material changes in research and development activities were reported. - FY2019-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥9,416 million. There were no material changes in research and development activities during the nine-month period.」
The company reaffirmed that research and development leveraging proprietary optical technologies is continuing and that there have been no material changes in research and development activities. Research and development expenses were ¥9,416 million. - FY2019-Q2RestatedAnnual report
「Under these circumstances, we have worked to secure revenue and profits by promoting research and development leveraging optical technologies cultivated over many years and developing products that meet customer needs.」
Research and development leveraging optical technologies and product development addressing customer needs have continued. Total research and development expenses were ¥6,372 million. - FY2019-Q1RestatedAnnual report
「Under these circumstances, we have worked to secure revenue and profits by continuing research and development leveraging our proprietary optical technologies and proactive capital investment for the future. Total research and development expenses for the three months ended 30 June of the current fiscal year were ¥3,095 million.」
The policy of continuing research and development leveraging proprietary optical technologies and capital investment was reiterated, and research and development expenses of ¥3,095 million were reported. - FY2018AdvancedAnnual report
「By combining it with our high-power laser, we achieved, for the first time in the world, pulse output exceeding 1 joule from a deep-ultraviolet solid-state laser.」
The company reported research and development expenses of ¥12,830 million, or 8.9% of revenue, for research and development based on proprietary optical technologies. Specific development achievements included attaining output exceeding 1 joule from a deep-ultraviolet solid-state laser, extending the wavelength and improving the sensitivity of a near-infrared image sensor, and doubling the scanning speed of an X-ray line sensor camera. - FY2018-Q3RestatedAnnual report
「Under these circumstances, we have worked to expand revenue and profits by continuing proactive capital investment for the future and promoting research and development leveraging our proprietary optical technologies cultivated over many years. Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥9,151 million.」
The policy of continuing research and development leveraging proprietary optical technologies and capital investment was reaffirmed, and total research and development expenses were reported at ¥9,151 million. - FY2018-Q2RestatedAnnual report
「Under these circumstances, we have worked to expand revenue and profits by continuing research and development leveraging our proprietary optical technologies cultivated over many years, as well as proactive capital investment, under our medium- to long-term vision for the future. Total research and development expenses for the six months ended 30 September of the current fiscal year were ¥6,057 million.」
Research and development leveraging proprietary optical technologies has continued under a medium- to long-term vision. Total research and development expenses were reported at ¥6,057 million. - FY2017-Q3RestatedAnnual report
「Under these circumstances, we have worked to secure revenue and profits by promoting research and development leveraging our proprietary optical technologies cultivated over many years and developing products that meet customer needs. Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥8,707 million.」
Research and development leveraging proprietary optical technologies and product development addressing customer needs have continued. Total research and development expenses were reported at ¥8,707 million. - FY2017-Q2RestatedAnnual report
「Under our medium- to long-term vision for the future, we have worked to secure revenue and profits by promoting research and development leveraging our proprietary optical technologies and continuing proactive capital investment.」
Research and development leveraging proprietary optical technologies has continued under a medium- to long-term vision. Total research and development expenses were reported at ¥5,824 million. - FY2017-Q1RestatedAnnual report
「We have worked to secure revenue and profits by continuing proactive capital investment for the future, promoting research and development in optical technologies, and developing new products that address customer needs.」
Research and development in optical technologies and new product development addressing customer needs have continued. Total research and development expenses were reported at ¥2,872 million. - FY2016-Q3First statedAnnual report
「We have worked to secure revenue and profits by promoting research and development based on our proprietary optical technologies cultivated over many years, while continuing to make proactive capital investments for future growth. Total research and development expenses for the nine months ended 31 December of the current fiscal year were ¥8,825 million.」
Research and development based on proprietary optical technologies formed the foundation, and total research and development expenses for the current nine-month period were also reported.